Recalibrating the kidney failure risk equation for a Mediterranean European population: reducing age and sex inequality.

IF 3.1 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Frontiers in Medicine Pub Date : 2025-01-29 eCollection Date: 2024-01-01 DOI:10.3389/fmed.2024.1497780
Daniel Bundó-Luque, Oriol Cunillera-Puértolas, Sílvia Cobo-Guerrero, José Romano, Ariadna Arbiol-Roca, José Alberto Domínguez-Alonso, Josep Maria Cruzado, Betlem Salvador-González
{"title":"Recalibrating the kidney failure risk equation for a Mediterranean European population: reducing age and sex inequality.","authors":"Daniel Bundó-Luque, Oriol Cunillera-Puértolas, Sílvia Cobo-Guerrero, José Romano, Ariadna Arbiol-Roca, José Alberto Domínguez-Alonso, Josep Maria Cruzado, Betlem Salvador-González","doi":"10.3389/fmed.2024.1497780","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Chronic kidney disease (CKD) patients may develop kidney failure (KF), receiving renal replacement therapy (RRT) in some cases. The Kidney Failure Risk Equation (KFRE-4), predicting RRT risk, is widely validated but not in a primary care Mediterranean European population. We aim to recalibrate KFRE-4 accordingly, considering death as a competing risk, to improve performance. Additionally, we recalibrate KFRE-4 for predicting KF, including all patients reaching CKD stage 5, not just those on RRT.</p><p><strong>Methods: </strong>Retrospective cohort study including individuals aged ≥50 years with confirmed glomerular filtration rate (eGFR) <60 mL/min/1.73m<sup>2</sup> and measured albumin-to-creatinine ratio (ACR). Dataset was split into training and test sets. New KFRE-4 models were developed in the training set and performance was evaluated in the test set: Base hazard adapted-KFRE (Basic-RRT), Cox reestimation (Cox- RRT), Fine and Gray RRT reestimation (FG-RRT), and Fine and Gray KF reestimation (FG-KF).</p><p><strong>Results: </strong>Among 165,371 primary care patients (58.1% female; mean age 78.1 years; mean eGFR 47.3 mL/min/1.73m<sup>2</sup>, median ACR 10.1 mg/g), original KFRE-4 showed good discrimination but poor calibration, overestimating RRT risk. Basic-RRT showed poorer performance. Cox-RRT and FG-RRT, enhancing the influence of old age and female sex, diminished overprediction. FG-RRT, considering death as a competing risk, resulted the best RRT model. Age and sex had less impact on KF prediction.</p><p><strong>Conclusion: </strong>A fully tailored recalibration model diminished RRT overprediction. Considering death as a competing event optimizes performance. Recalibrating for KF prediction offers a more inclusive approach in primary care, addressing the needs of women and elderly.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"11 ","pages":"1497780"},"PeriodicalIF":3.1000,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11813909/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2024.1497780","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Chronic kidney disease (CKD) patients may develop kidney failure (KF), receiving renal replacement therapy (RRT) in some cases. The Kidney Failure Risk Equation (KFRE-4), predicting RRT risk, is widely validated but not in a primary care Mediterranean European population. We aim to recalibrate KFRE-4 accordingly, considering death as a competing risk, to improve performance. Additionally, we recalibrate KFRE-4 for predicting KF, including all patients reaching CKD stage 5, not just those on RRT.

Methods: Retrospective cohort study including individuals aged ≥50 years with confirmed glomerular filtration rate (eGFR) <60 mL/min/1.73m2 and measured albumin-to-creatinine ratio (ACR). Dataset was split into training and test sets. New KFRE-4 models were developed in the training set and performance was evaluated in the test set: Base hazard adapted-KFRE (Basic-RRT), Cox reestimation (Cox- RRT), Fine and Gray RRT reestimation (FG-RRT), and Fine and Gray KF reestimation (FG-KF).

Results: Among 165,371 primary care patients (58.1% female; mean age 78.1 years; mean eGFR 47.3 mL/min/1.73m2, median ACR 10.1 mg/g), original KFRE-4 showed good discrimination but poor calibration, overestimating RRT risk. Basic-RRT showed poorer performance. Cox-RRT and FG-RRT, enhancing the influence of old age and female sex, diminished overprediction. FG-RRT, considering death as a competing risk, resulted the best RRT model. Age and sex had less impact on KF prediction.

Conclusion: A fully tailored recalibration model diminished RRT overprediction. Considering death as a competing event optimizes performance. Recalibrating for KF prediction offers a more inclusive approach in primary care, addressing the needs of women and elderly.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
重新校准地中海欧洲人口肾衰竭风险方程式:减少年龄和性别不平等。
慢性肾脏疾病(CKD)患者可能发展为肾衰竭(KF),在某些情况下接受肾脏替代治疗(RRT)。预测RRT风险的肾衰竭风险方程(kfr -4)得到了广泛验证,但在地中海欧洲初级保健人群中尚未得到验证。我们的目标是相应地重新校准kfr -4,将死亡视为一种竞争风险,以提高性能。此外,我们重新校准了kfr -4来预测KF,包括所有达到CKD第5期的患者,而不仅仅是那些接受RRT治疗的患者。方法:回顾性队列研究,纳入年龄≥50 岁,确认肾小球滤过率(eGFR) 2和测量白蛋白与肌酐比(ACR)的个体。数据集分为训练集和测试集。在训练集中建立了新的kfr -4模型,并在测试集中对其性能进行了评估:基础危险自适应kfre (Basic-RRT)、Cox重估(Cox- RRT)、Fine and Gray RRT重估(FG-RRT)和Fine and Gray KF重估(FG-KF)。结果:165371例初级保健患者中,女性占58.1%;平均年龄78.1 岁;平均eGFR 47.3 mL/min/1.73m2,中位ACR 10.1 mg/g),原始kfr -4鉴别性好,但校准效果差,高估了RRT风险。Basic-RRT表现较差。Cox-RRT和FG-RRT增强了年龄和女性的影响,减少了过度预测。FG-RRT将死亡作为竞争风险考虑,得到最佳RRT模型。年龄和性别对KF预测的影响较小。结论:完全量身定制的再校准模型减少了RRT的过度预测。将死亡视为一个竞争事件可以优化性能。重新校准KF预测提供了一种更具包容性的初级保健方法,解决了妇女和老年人的需求。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Frontiers in Medicine
Frontiers in Medicine Medicine-General Medicine
CiteScore
5.10
自引率
5.10%
发文量
3710
审稿时长
12 weeks
期刊介绍: Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate - the use of patient-reported outcomes under real world conditions - the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines - the scientific bases for guidelines and decisions from regulatory authorities - access to medicinal products and medical devices worldwide - addressing the grand health challenges around the world
期刊最新文献
Aspirin vs. enoxaparin for thromboprophylaxis after total hip arthroplasty, total knee arthroplasty, or hip fracture surgery-a systematic review and meta-analysis. Changes of individual choroidal thickness post-uneventful cataract surgery determined by spectral-domain optical coherence tomography over a 3-month period. Case Report: Successful endoscopic treatment of gastric outlet obstruction due to duodenal persimmon phytobezoar. Diagnostic performance of dual-energy CT for differentiating acute intracranial hemorrhage from contrast staining: a systematic review and meta-analysis. Schistosoma infection as a cause of myeloradiculopathy: case report from Mozambique and systematic review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1